Buradasınız

Anasayfa » Content

Böbrek Fonksiyonları Bozuk Hastalarda Preoperatif Değerlendirme

Preoperative Evaluation of the Patients With Renal Dysfuntion

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2005

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Renal function abnormalities are frequently seen in patients who have an operation during preoperative and postoperative period. There may be deficiencies at management of therapy during preoperative and postoperative period, because differential diag¬ nosis can't be done sufficiently in patients who have renal function abnormality. These deficiencies cause complications and as a re¬ sult, enhance morbidity and mortality. In our review, we aimed to light the way for the differential diagnosis and treatment of patients who have renal function abnormality during perioperative period.
Bookmark/Search this post with
Abstract (Original Language): 
Preoperatif ve postoperatif dönemde cerrahi hastalarında böbrek fonksiyon bozuklukları sıklıkla görülmektedir. Böbrek fonksiyon bozukluğu olan hastalarda ayırıcı tanının iyi yapılamaması nedeni ile preoperatif ve postoperatif dönemde tedavinin düzenlenmesin¬ de eksiklikler olabilmektedir. Bu eksiklikler de komplikasyonlara ve sonuçta mortalite ve morbiditede artışa neden olmaktadır. Bu derleme makalemizde, böbrek fonksiyonları bozuk olan hastaların perioperatif dönemde ayırıcı tanı ve tedavilerine ışık tu¬ tulması amaçlanmıştır.
FULL TEXT (PDF): 
PDF icon pdf_tndt_531.pdf
  • 3
  • Turkish

REFERENCES

References: 

1. NKF-DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 2000;37(suppl l):1-266.
2. United States Renal Data System. USRDS 2001 Annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Kidney Diseases; 2001.
3. Joseph AJ, Cohn SL. Perioperative care of the patient with renal failure. Med Clin Nort Am 2003;87:193-210.
4. Chertow GM, Lazarus JM, Christiansen CL, et al. Preoperative renal risk stratification. Circulation 1997;95(4):878-84.
5. Suen WS, Mok CK, Chiu SW, et al. Risk factors for development of acute renal failure requiring dialysis in patients un¬dergoing cardiac surgery. Angiology 1998;49:789-800.
6. Skorecki K, Green J, Brenner BM. Chronic renal failure. In: Braunwald E, Fauci As, Kasper DL, et al (eds), Harrison's
Principles of Internal Medicine. McGraw-Hill Co, London
2001:1551-1561.
7. Kellerman PS. Perioperative care of the renal patient. Arch Intern Med 1994;154(15):1674-1688.
8. Schlant RC, Eagle KA. Perioperative evaluation and manage¬ment of patients with known or suspected cardiovascular di¬sease who undergo noncardiac surgery. In: Alexander RD, et al. (Eds). Hurst's The Heart, 9th ed. New York. Mc Graw-Hill Health Professions Division, 1998; pp 2243-47.
9. Choundry D, Ahmed Z. Drug-induced nephrotoxicity. Med Clin Nort Am 1997;81:705-711.
10. Anderson RJ, O'Brien M, MaWhinney S, et al. Mild renal fa¬ilure is associated with adverse outcome after cardiac valve
surgery. Am J Kidney Dis 2000;35(6):1127-34.
11. Neveu H, Kleinknecht, Briet F, et al. Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. Nephrol Dial Transplant 1996;11(2):293-
9.
12. Humes HD. Aminoglycoside nephrotoxicity. Kidney Int 1998;
33(4):900-11.
13. Liano F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter community-based study. Kidney Int 1996;50:811-8.
14. Davison
MA
, Grünfeld JP. History and clinical examination of the patient with renal disease. In: Davison, Cameron, Grün-feld, Kerr, Ritz, Winearls (eds), Oxford Textbook of Clinical Nephrology. Oxford University Press 1998 (sec. ed.): 4-17.
15. Albert MA, Antman EM. Preoperative evaluation for cardiac surgery. In: Cohn LH, Edmunds LH Jr (eds), Cardiac Surgery
in the Adult. New York: McGraw-Hill, 2003:235-248.
16. Foley RN, Parfrey PS, Sarnack MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(5,suppl 3):s112-119.
17. Koch M, Gradaus F, Schoebel DC, et al. Relevance of con¬ventional cardiovascular risk factors for the prediction of co¬ronary artery disease in diabetic patients on renal replace¬ment therapy. Nephrol Dial Transplant 1997;12(6):1187-91.
18. Schlant RC, Alexander RW. Diagnosis and management of patients with chronic ischemic heart disease. In: Alexander RD, et al. (Eds). Hurst's The Heart, 9th ed. New York. Mc Graw-Hill Health Professions Division, 1998; pp 1275-1297.
19. Elsner D. How to diagnose and treat coronary artery disease in the uraemic patient: an update. Nephrol Dial Transplant
2001;16(6):1103-1108.
20. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocar-diographic disease in patients starting end-stage renal disease
therapy. Kidney Int 1995;47(1):186-192.
21. Go RT, Marwick TH, MacIntyre WJ, et al. A prospective com¬parison of rubidium 82 PET and thallium 201 SPECT myocar-dial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990;
31:1906-8.
22. Coley CM, Field TS, Abraham SA,et al. Usefulness of dipyrida-mole-thallium scanning for preoperative evaluation of cardiac risk for nonvascular surgery. Am J Cardiol 1992;69:1280-8.
23. Dahan M, Viron BM, Faraggi M, et al. Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patient. Kidney Int 1998;
54:255-62.
24. Poldermans D, Arnese M, Fioretti PM, et al. Sustained prog¬nostic value of dobutamine stress echocardiography for late
Official Journal of the Turkish Society of Nephrology / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi
117
£ Preoperative Evaluation of the Patients With Renal Dysfuntion
cardiac events after major noncardiac vascular surgery. Circu¬lation 1997;95:53-59.
25. Reis G, Marcovitz PA, Leichtman AB, et al. Usefulness of do-butamine stress echocardiography in detecting coronary ar¬tery disease in end-stage renal disease. Am J Cardiol 1995;
75:707-710.
26. Herzog CA, Marwick TH, Pheley AM, et al. Dobutamine stress echocardiography for the detection of significant coro¬nary artery disease in renal transplant candidates. Am J Kid¬ney Dis 1999;33:1080-1090.
27.
Ersanl
ı M. Kalp hastasının kalp dışı cerrahi öncesi değerlendirilmesinde klinik kardiyoloğun yaklaşımı. Türk Kardiyol Dern Arş 2001;29:117-130.
28. Eagle KA, Brundage BH, Chaitman BR, et al. Report of Ame¬rican College of Cardiology/American Heart Association Task Force on Practice Guidelines (Commitee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Guideli¬nes for perioperative cardiovascular evaluation for noncardi-ac surgery. Circulation 1996;93:1278-1317.
29. Goldman L. General anesthesia and noncardiac surgery in patients with heart disease. In: Braunwald E (ed), Heart Di¬sease. 5th Edition. Philadelphia. W.B. Saunders Company,
1997; p 1756.
30. Mehta RH, Bossone E, Eagle KA. Perioperative cardiac risk as¬sessment for noncardiac surgery. Cardiologia 1999;44:409-18.
31. Daugirdas JT. Dialysis hypotension: A hemodynamic analy¬sis. Kidney Int 1991;39:233-246.
32. Leunissen KML, Kooman JP, Van der Sande FM: Acute dialy¬sis complications. In: Lomeire N, Mehta RL (ed), Complicati¬ons of Dialysis. Marcel Dekker Inc, New York, 2000; 69-83.
33. Tzamaloukas AH, Ramdeen G. Interdialytic weight gain: role of salt and water intake. Int J Artif Organs 1999;22:64-68.
34. "Mandelbaum A, Ritz E. Vena cava diameter mesaurement for estimation of dry weight in hemodialysis patients. Nephrol Dial Transplant 1996; 11 (Supp 2): 24-27.
35. Daugirdas JT. Preventing and managing hypotension. Semin Dial 1994;7:276-283.
36. Sang GL, Kovithavongs C, Ulan R, Kjellstrand CM. Sodium rampling in hemodialysis: a study of benefical and adverse effects. Am J Kidney Dis 1997;29:669-677.
37. Koomans HA, Geers AB, Dorhout Mees EJ. Plasma volume recovery after ultrafiltration in patients with chronic renal fa¬ilure. Kidney Int 1984;26:848-854.
38. Sherman RA, Torres F, Cody RP. Postprandial blood pressu¬re changes during hemodialysis. Am J Kidney Dis 1988;12:
37-39.
39. Cruz DN, Mahnensmith RL, Brickel HM, Parazella MA. Mi-dodrine and cool dialysate are effective therapies for sympto¬matic intradialytic hypotension. Am J Kidney Dis 1999;33:
920-926.
40. Sherman RA, Rubin MP, Cody RP, Eisinger RP. Amelioration of hemodialysis-associated hypotension by the use of cool dialysate. Am J Kid Dis 1985;5:124 -127.
41. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update. Am J Kidney Dis 2001;37(1, suppl 1):s182-288.
42. Eberst ME, Berkowitz LR. Hemostosis in renal disease: Pat-hophysiology and management. Am J Med 1994;96:168.
43. Mannucci PM. Hemostatic drugs. N Engl J Med 1998;339:245.
44. Livio M, Mannucci PM, Vigano G, et al. Conjugated estrogens for the management of bleeding associated with renal failu¬re. N Engl J Med 1986;315(12):731-735.
45. Gavin LA. Perioperative management of the diabetic patient.
Endocrinol Metab Clin North Am 1992;21:457-475.
46. Henrich WL. Hemodynamic instability during hemodialysis.
Kidney Int 1986;30:605-612.
47. Yalcin AU, Sahin G, Erol M, Bal C. Sertraline hydrochloride treatment for patients with hemodialysis hypotension. Blood
Purif 2002;20:150-153.
48. Yalcin AU, Kudaiberdieva G, Sahin G, Gorenek B, Akcar N, Kuskus S, Bayrak F, Timuralp B. Effect of sertraline hydroch-loride on cardiac autonomic dysfunction in patients with he-modialysis induced hypotension. Nephron Physiolology
2003;93:21-28.
49. Rose BD. Treatment of hyperkalemia. In: Rose BD (ed), Up-
ToDate. Release 11.3; 2004.
50. Shemin D, Bostom AG, Laliberty P, et al. Residual renal func¬tion and mortality risk in hemodialysis patients. Am J Kidney
Dis 2001;38:85-90.
51. Benett WM, Aronoff Gr, Golper TA, et al. Drug prescribing in renal failure: dosing guidelines for adults. 4th edition. Phila¬delphia: American College of Physicians; 2000.
52. Peterson GM, Randall CT, Peterson J. Plasma levels of morp¬hine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administrati¬on. Eur J Clin Pharmacol 1990;38:121-124.
53. Malhotra V, Diwam S. Anesthesia and the renal and genito¬urinary systems. In: Miller R (ed), Anesthesia. Fifth edition. New York: Churchill Livingstone; 2000.
54. Ickx B, Cockshott ID, Barvais L. Propofol infusion for induc¬tion and maintenance of anasthesia in patients with end-sta¬ge renal disease. Br J Anaesth 1998;81:854-860.

Thank you for copying data from http://www.arastirmax.com